Cardiology | Antiarrhythmic Drug Guide | Class Ia | Quinidine
||Don't! Frequent occurrence of hypotension and cardiovascular collapse!
||Quinidine sulfate: 30-60 mg/kg/day (450-900 mg/m2/day) in children, 10 mg/kg/day in adults, divided q 6 hours.
20% higher for gluconate, given q 8-12 hours
||2-6 ug/ml >7 ug/ml highly correlated with toxicity.
||Peak levels 1-3 hours for sulfate, 4 hours for gluconate after oral dose. Elimination half-life 6.3 hours in adults. 4.7 hours in 4-6 year olds, 6 hours in neonates.
||Similar to those for procainamide
||Potentiation of warfarin effect. Mean 100-150% increase in digoxin levels. (Probably doesn't occur under 2 months of age.) Levels increased in congestive heart failure. Elimination impaired by cimetidine, amiodarone. Elimination accelerated by phenytoin, propranolol, rifampin. Contraindicated with verapamil: cardiovascular collapse and hypotension frequent.
||Quinidine sulfate tablets: 200, 300 mg.
Quinidex Extentabs (Q. sulfate): 1/3 released immediately, 2/3 slow release in GI tract. 300 mg tablets.
Quiniglute Duratabs: non-scored tablets: 324 mg
|FDA approval in children
Return to Antiarrhythmic Drug Guide page